3B Films Reports Consolidated Profit Of Rs 1 Crore For H1 FY27

MEDIA-AND-ENTERTAINMENT
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
3B Films Reports Consolidated Profit Of Rs 1 Crore For H1 FY27

3B Films reported mixed results for the half-year ending September 2026. While the standalone business faced a widened net loss of Rs 1.57 crore, the consolidated performance turned profitable at Rs 1 crore, signaling a positive swing compared to the previous year.

3B Films Reports Consolidated Profit of Rs 1 Crore for H1 FY27

Consolidated Profit: Rs 1.00 Crore
Standalone Net Loss: Rs 1.57 Crore

Reader Takeaway: Consolidated profitability improved year-on-year, but standalone operations show deepening losses requiring closer management oversight.

What just happened

3B Films Ltd has released its financial results for the half-year ended September 30, 2026. The company reported a consolidated net profit of Rs 1 crore on revenue of Rs 52.31 crore. In contrast, the company’s standalone operations reported a net loss of Rs 1.57 crore on revenue of Rs 28.01 crore.

Why this matters

The diverging performance between standalone and consolidated figures is the key highlight for shareholders. While the standalone business continues to see its losses widen from Rs 0.95 crore in the same period last year to Rs 1.57 crore currently, the consolidated entity has successfully reversed its position from a loss of Rs 0.95 crore last year to a profit of Rs 1 crore this year.

Context metrics

During the same period last year, the company's standalone revenue stood at Rs 25.72 crore. The current basic EPS stands at -0.64 for standalone and 0.40 for consolidated operations. The trading window remains closed for designated persons until 48 hours after the declaration of these results.

What to track next

Investors should look for further disclosures regarding the specific subsidiaries or operational segments that contributed to the consolidated turnaround. Understanding how the standalone losses are being managed will be critical for assessing the firm's long-term financial health.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.